David Gobel
Directeur/Membre du Conseil chez ORGANOVO HOLDINGS, INC.
Fortune : 19 372 $ au 30/04/2024
Postes actifs de David Gobel
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ORGANOVO HOLDINGS, INC. | Directeur/Membre du Conseil | 15/09/2020 | - |
| Independent Dir/Board Member | 15/09/2020 | - | |
Oisin Biotechnologies, Inc.
 Oisin Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Oisin Biotechnologies, Inc. operates as a drug development company. It engages in the provision of biological solutions to degenerative aging conditions. The company was founded by Gary Hudson, Kevin Perrott, Matthew Scholz and John Lewis in 2014 and is headquartered in Seattle, WA. | Directeur/Membre du Conseil | 01/12/2014 | - |
| Independent Dir/Board Member | 01/12/2014 | - | |
Methuselah Capital Management LLC
 Methuselah Capital Management LLC Investment ManagersFinance Methuselah Capital Management LLC (Methuselah Fund) is a venture capital firm, a subsidiary of Methuselah Foundation founded in 2016 by Sergio Ruiz and David Gobel. The firm is headquartered in Springfield, Virginia. | Directeur Général | 01/01/2017 | - |
| Fondateur | 01/01/2017 | - | |
Leucadia Therapeutics, Inc.
 Leucadia Therapeutics, Inc. Medical SpecialtiesHealth Technology Leucadia Therapeutics, Inc. develops diagnostic algorithm for Alzheimer disease prevention and treatment. The firm?s therapeutic device is under pre-clinical testing to delay or prevent patients with mild cognitive impairment (MCI) from progressing to Alzheimer's disease. The company was founded by Doug Ethell and is headquartered in Delaware. | Directeur/Membre du Conseil | 01/10/2015 | - |
| Methuselah Foundation | Directeur Général | 01/09/2001 | - |
| Fondateur | 01/09/2001 | - | |
Turn Biotechnologies, Inc.
 Turn Biotechnologies, Inc. BiotechnologyHealth Technology Turn Biotechnologies, Inc. engages in the development of solutions for reversing aging and age-related diseases. It focuses on achieving rejuvenation across cellular aging hallmarks in human fibroblasts and endothelial cells without the loss cellular identity. The company was founded by Jay Sarkar, Marco Quarta, and Vittorio Sebastiano and is headquartered in Mountain View, CA. | Président | 01/05/2020 | - |
| Directeur/Membre du Conseil | 01/07/2018 | 01/05/2020 |
Historique de carrière de David Gobel
Anciens postes connus de David Gobel
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Volumetric Biotechnologies, Inc. | Directeur/Membre du Conseil | 01/04/2018 | 01/01/2020 |
| Transportation Security Administration | Corporate Officer/Principal | 01/01/2009 | 01/03/2013 |
Statistiques
Internationale
| Etats-Unis | 9 |
Opérationnelle
| Director/Board Member | 5 |
| Independent Dir/Board Member | 2 |
| Chief Executive Officer | 2 |
Sectorielle
| Health Technology | 5 |
| Government | 2 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ORGANOVO HOLDINGS, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
| Transportation Security Administration | Government |
| Methuselah Foundation | |
Oisin Biotechnologies, Inc.
Oisin Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Oisin Biotechnologies, Inc. operates as a drug development company. It engages in the provision of biological solutions to degenerative aging conditions. The company was founded by Gary Hudson, Kevin Perrott, Matthew Scholz and John Lewis in 2014 and is headquartered in Seattle, WA. | Health Technology |
Methuselah Capital Management LLC
Methuselah Capital Management LLC Investment ManagersFinance Methuselah Capital Management LLC (Methuselah Fund) is a venture capital firm, a subsidiary of Methuselah Foundation founded in 2016 by Sergio Ruiz and David Gobel. The firm is headquartered in Springfield, Virginia. | Finance |
Leucadia Therapeutics, Inc.
Leucadia Therapeutics, Inc. Medical SpecialtiesHealth Technology Leucadia Therapeutics, Inc. develops diagnostic algorithm for Alzheimer disease prevention and treatment. The firm?s therapeutic device is under pre-clinical testing to delay or prevent patients with mild cognitive impairment (MCI) from progressing to Alzheimer's disease. The company was founded by Doug Ethell and is headquartered in Delaware. | Health Technology |
Turn Biotechnologies, Inc.
Turn Biotechnologies, Inc. BiotechnologyHealth Technology Turn Biotechnologies, Inc. engages in the development of solutions for reversing aging and age-related diseases. It focuses on achieving rejuvenation across cellular aging hallmarks in human fibroblasts and endothelial cells without the loss cellular identity. The company was founded by Jay Sarkar, Marco Quarta, and Vittorio Sebastiano and is headquartered in Mountain View, CA. | Health Technology |
| Volumetric Biotechnologies, Inc. |
- Bourse
- Insiders
- David Gobel
- Expérience